SYDNEY, July 21, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), a leadin...
* Capital raise nets $85 million from Existing Shareholders, Existing Institutional Investors, an...
* First patient dosed with QBiotics' lead oncology molecule tigilanol tiglate in combination with...
* Island's lead asset, ISLA-101 granted key patent from United Stated Patent & Trademark Office ...